# FDA 483 - Memorial Hospital For Cancer & Allied Diseases - May 29, 2019

Source: https://www.globalkeysolutions.net/records/483/memorial-hospital-for-cancer-allied-diseases/9e8a38e7-c98f-43c9-a00e-b7af5b01aac5

> FDA 483 for Memorial Hospital For Cancer & Allied Diseases on May 29, 2019. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Memorial Hospital For Cancer & Allied Diseases
- Inspection Date: 2019-05-29
- Product Type: biologics
- Office Name: Division of Human and Animal Food Operations - East I
- Summary: Memorial Hospital For Cancer & Allied Diseases, a blood bank in New York, was inspected by the FDA from May 13-29, 2019. The inspection revealed significant deficiencies in record-keeping, adherence to standard operating procedures, failure to investigate product deviations, and untimely reporting of biological product deviations. These issues indicate a lack of robust quality control and compliance with regulatory requirements for blood and blood component processing and distribution.

## Related Documents

- [483 - 2025-02-13](https://www.globalkeysolutions.net/records/483/memorial-hospital-for-cancer-allied-diseases/5115195a-8b3a-459b-8435-8e34d30ce4b9)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.globalkeysolutions.net/companies/memorial-hospital-for-cancer-allied-diseases/52f00fc8-a958-4fce-b4bf-07f18baf51a2

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-east-i/a807f00e-d780-40b8-b233-1eb92ece8961